Main Article Content
Abstract
Keywords
Article Details
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
References
- Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain, Behavior, and Immunity. 2020;87:59-73.
- Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, et al. Therapeutic plasma exchange in adults with severe COVID-19 infection. International Journal of Infectious Diseases. International Society for Infectious Diseases. 2020;99:214–8.
- Morath C, Weigand MA, Zeier M, Speer C, Tiwari-Heckler S, Merle U. Plasma exchange in critically ill COVID-19 patients. Critical Care. Critical Care; 2020;24(1):1–4.
- Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: An argument for the use of therapeutic plasma exchange for fulminant COVID-19. Critical Care. 2020;24(1):1–3.
- Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. Journal of Internal Medicine. 2020;(June):1–15.
- Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 patients. Journal of Intensive Care Medicine. 2020;35(9):827–35.
- Keith P, Day M, Choe C, Perkins L, Moyer L, Hays E, et al. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure. SAGE Open Medical Case Reports. 2020;8:2050313X2093347.
- Song CY, Xu J, He JQ, Lu YQ. COVID-19 early warning score: A multi-parameter screening tool to identify highly suspected patients. medRxiv. 2020.
- Erlina B, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Pedoman tatalaksana COVID-19. 2nd ed. Jakarta, 2020 p. 47–68.
- Zhuplatov SB, Zhuplatov IS. Removal of endotoxins and cytokines by plasmapheresis filtration with plasma exchange therapy (TPE) could benefit patients with Covid-19 in critical condition. 2020;10(5):85–9.
- Sokolov AA, Solovyev AG. Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world’s first successful plasmapheresis. Therapeutic Apheresis and Dialysis. 2014;18(2):117–21.
- Santis GC De, Correa L, Oliveira O De, Maltoni G, Pina B De, Prado A, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: The seventh special issue. Journal Of Clinical Apheresis. 2011;185:181–5.
- Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. Journal of Leukocyte Biology. 2020;108(1):17–41.
- Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L, Ogan A, et al. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: A retrospective study. Critical Care. Critical Care; 2020;24(1):4–7.
- Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clinical Immunology. 2020;214:24–6.
References
Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain, Behavior, and Immunity. 2020;87:59-73.
Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, et al. Therapeutic plasma exchange in adults with severe COVID-19 infection. International Journal of Infectious Diseases. International Society for Infectious Diseases. 2020;99:214–8.
Morath C, Weigand MA, Zeier M, Speer C, Tiwari-Heckler S, Merle U. Plasma exchange in critically ill COVID-19 patients. Critical Care. Critical Care; 2020;24(1):1–4.
Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: An argument for the use of therapeutic plasma exchange for fulminant COVID-19. Critical Care. 2020;24(1):1–3.
Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. Journal of Internal Medicine. 2020;(June):1–15.
Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 patients. Journal of Intensive Care Medicine. 2020;35(9):827–35.
Keith P, Day M, Choe C, Perkins L, Moyer L, Hays E, et al. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure. SAGE Open Medical Case Reports. 2020;8:2050313X2093347.
Song CY, Xu J, He JQ, Lu YQ. COVID-19 early warning score: A multi-parameter screening tool to identify highly suspected patients. medRxiv. 2020.
Erlina B, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Pedoman tatalaksana COVID-19. 2nd ed. Jakarta, 2020 p. 47–68.
Zhuplatov SB, Zhuplatov IS. Removal of endotoxins and cytokines by plasmapheresis filtration with plasma exchange therapy (TPE) could benefit patients with Covid-19 in critical condition. 2020;10(5):85–9.
Sokolov AA, Solovyev AG. Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world’s first successful plasmapheresis. Therapeutic Apheresis and Dialysis. 2014;18(2):117–21.
Santis GC De, Correa L, Oliveira O De, Maltoni G, Pina B De, Prado A, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: The seventh special issue. Journal Of Clinical Apheresis. 2011;185:181–5.
Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. Journal of Leukocyte Biology. 2020;108(1):17–41.
Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L, Ogan A, et al. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: A retrospective study. Critical Care. Critical Care; 2020;24(1):4–7.
Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clinical Immunology. 2020;214:24–6.